September 3, 2010
| Bio-IT World > Discovery Zone

Discovery Zone

Loading...

First Base
By Kevin Davies

Kevin Davies, Ph.D.Editor-in-ChiefMarch 10, 2003 | FEW SCIENTISTS or commentators can summon the chutzpah to lecture on the topic of "What remains to be discovered" and get away with it. But Sir John Maddox, editor emeritus of Nature and author of a book of the same title, did just that in his closing address at the Miami Nature Biotechnology Winter Symposia last month. The meeting marked the 50th jubilee of the discovery of the double helix, as well as the founding of the University of Miami School of Medicine.

While Nature's prestige was indubitably sealed by the famous 1953 publication of Watson and Crick's 900-word letter, Maddox consistently upheld the journal's lofty reputation during his two stints as editor, from 1966-1973 and 1980-1995, not only publishing a steady stream of cutting-edge research but also jumping enthusiastically into the trenches to tackle and/or exacerbate controversial issues such as the viral cause of AIDS, cold fusion, animal telepathy, and the alleged homeopathic memory of water. In an extraordinary episode known as the Benveniste affair, Maddox elected to publish results (under the heading "Hypothesis") purporting to show that water could retain the structural imprint of proteins. He then accompanied his friend, the Amazing Randi, to Paris to investigate and ultimately debunk the research.

John Maddox echoes the call for a new initiative in systems biology.
Despite the remarkable progress in DNA research, genetic engineering, and the genome project, Maddox maintains that many unresolved questions remain in molecular biology. The process of reading genes, or transcription, remains a puzzle: How does the DNA, so tightly packaged in chromosomes, disentangle itself to allow individual gene sequences to be read? How do the DNA motifs that constitute gene promoters and enhancers work at the chemical and genetic level? And why do some genes have to be edited in the nucleus — surely evolution should have discarded such an inefficient process by now? The stage is set for rapid advances in the field of evolution. "Darwin didn't tell us how species differ from each other, but geneticists now can."

In cell biology, Maddox marveled at the sophisticated 3-D pictures of complex molecular structures so commonly displayed at meetings, such as the nuclear pore complex and ribosomes (the sites of protein synthesis). The cellular machinery will be sorted out in the next 10 years, Maddox predicted, after which it will become boring. But what chemical principles govern protein function and complex formation? And how are molecular machines, composed of dozens of discrete proteins, actually assembled?

Maddox also echoed the call of Leroy Hood, who spoke earlier at the conference, for a new initiative in systems biology. "It's high time molecular biology became quantitative," Maddox said. "It cries out to a physicist — as I used to be — for modeling. Modeling isn't a crutch ... it's the opposite; it's a way of suggesting experiments to do, gaps in your understanding."


Malfunctions of the Mind 
Major questions remain unanswered in other areas, too. 2003 also happens to be the 50th anniversary of Stanley Miller's classic synthesis of organic compounds from rudimentary ingredients, but advances in explaining the origin of life since then have disappointed. The function of the brain remains a mystery — particularly the formation of memories, how the brain makes decisions, and the molecular underpinnings of consciousness.

Maddox spoke passionately against the curiously entrenched public acceptance of genetic determinism. One of the embarrassing oversimplifications of the genome era is the mistaken assumption that genes control all human traits, a list that might include avarice, bad temper, tardiness, the inability to get out of bed, and more. While most if not all disease genes for single-gene (monogenic) disorders such as cystic fibrosis have been identified, Maddox doubts that the public readily appreciates the polygenic nature of most common diseases, such as diabetes.

Trials and Frontiers 
Bio·IT World will present two symposia at the Bio-ITWorld Conference & Expo in Boston (March 25-27). On the afternoon of March 25, please join us for either a session on e-clinical trials (hosted by Forrester Research analyst Michael Barrett) or a session exploring post-genomic frontiers. Both will feature five outstanding speakers, addressing two vital aspects of bio-IT. Details can be found at www.bioitworldexpo.com.
This is a concern, particularly as research into complex diseases, notably mental illness, starts to pay dividends. Maddox has helped the British mental health charity SANE build the Prince of Wales International Centre for SANE Research in Oxford, dedicated to schizophrenia and other malfunctions of the mind, which officially opened last month. One intriguing possibility under investigation is that schizophrenia may have arisen as a consequence of the evolution of language in humans, suggesting that genomic differences between humans and chimps might reveal a genetic culprit.

Musing on the perennial issue of nature versus nurture, Maddox implored researchers to pay more attention to the role of the environment in shaping behavior. His own family is a case in point. His wife, Brenda, the highly regarded biographer of Rosalind Franklin, is turning her attention from the dark lady of DNA to the iron lady of the U.K.: Margaret Thatcher. His daughter Bronwen is the foreign editor for The Times. And his son Bruno, the Harvard-educated former editor of the now defunct Spy magazine, is wrapping up his second book, a modest little number provisionally entitled TB2, said to be a sequel to The Bible.

Kevin Davies, Ph.D.
Editor-in-Chief
Bio·IT World 






White Papers & Special Reports

oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series!

Covering a broad array of topics within the life sciences and drug development industries, these complimentary 90-minute web symposiums provide an interactive platform to learn more about cutting-edge bio-IT topics through expert analysis and discussions.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
Recorded on August 3, 2010
Sponsored by: Pegasystems
Program Details | Access Recording 

Next Gen Data Management for Next Gen Life Sciences
September 8, 2010 | 1:00pm - 2:30pm EST
Sponsored by Quantum
Program Details | Register Today 

 


Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.